International Journal of Radiation Oncology published a 10-year post-treatment analysis of the German ARO 96-02 trial. It reported that prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy should receive earlier, more aggressive radiation therapy treatment. The German ARO 96-02 trial is a prospective clinical trial that compared a wait-and-see approach versus an adjuvant radiation therapy approach for patients ...
You have just read an article categorized health
titled Aggressive Radiation Therapy for Prostate Cancer Patients With Prostate Specific Antigen.
Written by:
editor - Saturday, February 14, 2015
There are currently no comments for "Aggressive Radiation Therapy for Prostate Cancer Patients With Prostate Specific Antigen"
Post a Comment